Bristol-Myers Directors Sued in NY Over FCPA Inaction
By Martin O'Sullivan · August 8, 2016, 3:31 PM EDT
An investor has launched a derivative suit in New York alleging that directors of Bristol-Myers Squibb Co. failed to respond to warning signs that its representatives in China were bribing state-owned...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login